This information could include general advice for managing diabetes mellitus; complication risk‐reduction strategies; information on symptoms and signs of DKA; what to do in the event of postoperative illness; specifics of SGLT2 inhibitors dose management, and contact information for assistance. This evidence concerns the gene SLC5A2 and diabetes mellitus.